Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 4.070
-0.050 (-1.21%)
Feb 3, 2026, 3:04 PM CST
Dezhan Healthcare Company Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -89.53 | -20.41 | 83.31 | -46.95 | -57.58 | 284.54 |
Depreciation & Amortization | 83.99 | 83.99 | 83.67 | 94.2 | 84.52 | 68.57 |
Other Amortization | 6.28 | 6.28 | 5.19 | 6.96 | 2.54 | 2.8 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | 0.03 | -0.33 | -0.02 | -0 |
Asset Writedown & Restructuring Costs | 1.56 | 1.56 | 7.23 | 41.98 | 14.51 | 2.49 |
Loss (Gain) From Sale of Investments | 19.87 | 19.87 | -80.31 | -19.19 | -32.09 | -95.45 |
Provision & Write-off of Bad Debts | 5.84 | 5.84 | 4.82 | -0.05 | 1.04 | 9.28 |
Other Operating Activities | 109.48 | -11.13 | -5.27 | 5 | 138.44 | -20.05 |
Change in Accounts Receivable | -97.09 | -97.09 | 168.74 | 9.28 | 19.89 | 473.8 |
Change in Inventory | 9.88 | 9.88 | 130.78 | -22.26 | 35.58 | 20.06 |
Change in Accounts Payable | 5.79 | 5.79 | -282.65 | 86.07 | -184.93 | 67.91 |
Operating Cash Flow | 36.9 | -14.59 | 127.87 | 161.72 | 42.41 | 827.54 |
Operating Cash Flow Growth | - | - | -20.93% | 281.32% | -94.88% | -46.91% |
Capital Expenditures | -226.18 | -166.55 | -159.73 | -67.56 | -126.92 | -110.28 |
Sale of Property, Plant & Equipment | 0.39 | 0.09 | 0.01 | 1.48 | 0.06 | 0.02 |
Cash Acquisitions | - | - | -10.36 | - | - | -276.93 |
Divestitures | - | - | -51.9 | - | - | - |
Investment in Securities | -35 | -12.91 | 400 | 1,018 | 185.58 | -261.5 |
Other Investing Activities | 0 | - | - | 56.67 | 37.76 | 104.15 |
Investing Cash Flow | -260.78 | -179.38 | 178.02 | 1,009 | 96.47 | -544.54 |
Short-Term Debt Issued | - | - | 4.09 | - | 1.2 | 9.8 |
Total Debt Issued | 114.8 | - | 4.09 | - | 1.2 | 9.8 |
Short-Term Debt Repaid | - | -0.47 | -1.93 | - | -1.2 | -5.63 |
Long-Term Debt Repaid | - | -4.26 | -2.39 | -3.2 | -7.12 | - |
Total Debt Repaid | -6.21 | -4.73 | -4.32 | -3.2 | -8.32 | -5.63 |
Net Debt Issued (Repaid) | 108.59 | -4.73 | -0.23 | -3.2 | -7.12 | 4.17 |
Issuance of Common Stock | 4 | - | - | - | - | 39.98 |
Repurchase of Common Stock | -73.28 | -73.28 | -159.85 | -11.83 | -10.98 | - |
Common Dividends Paid | -0.9 | -0.08 | -0.03 | - | -470.29 | -0.03 |
Other Financing Activities | -70.46 | - | - | -33.1 | - | 9.91 |
Financing Cash Flow | -32.05 | -78.09 | -160.11 | -48.12 | -488.39 | 54.03 |
Foreign Exchange Rate Adjustments | 0 | 0 | 0 | 0 | -0.22 | -0.39 |
Net Cash Flow | -255.93 | -272.05 | 145.79 | 1,123 | -349.74 | 336.64 |
Free Cash Flow | -189.27 | -181.14 | -31.86 | 94.16 | -84.51 | 717.25 |
Free Cash Flow Growth | - | - | - | - | - | -51.98% |
Free Cash Flow Margin | -48.59% | -38.83% | -6.40% | 16.50% | -11.51% | 74.49% |
Free Cash Flow Per Share | -0.09 | -0.08 | -0.01 | 0.04 | -0.04 | 0.32 |
Cash Interest Paid | 0.09 | 0.09 | 0.11 | 0.12 | 0.15 | 0.13 |
Cash Income Tax Paid | 54.08 | 64.16 | 76.64 | 82.18 | 118.72 | 209.96 |
Levered Free Cash Flow | -221.44 | -193.47 | -128.19 | 137.18 | 37.09 | 373.92 |
Unlevered Free Cash Flow | -220.34 | -193.24 | -127.96 | 137.62 | 37.5 | 374.04 |
Change in Working Capital | -100.62 | -100.62 | 29.19 | 80.1 | -108.95 | 575.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.